NorthView Acquisition Corp financial data

Symbol
NVAC, NVACR, NVACW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
207 West 25 Th St, 9 Th Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q4 2023 - Feb 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 17.1 % -90.9%
Debt-to-equity -124 % +39.5%
Return On Equity -35.4 % +94.7%
Return On Assets 10.7 % +190%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.03M shares -75.1%
Common Stock, Shares, Outstanding 5.19M shares 0%
Entity Public Float 192M USD
Common Stock, Value, Issued 519 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.19M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.19M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -1.51M USD -18.7%
Nonoperating Income (Expense) 3.13M USD -65%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.62M USD -78.9%
Income Tax Expense (Benefit) 457K USD -8.5%
Net Income (Loss) Attributable to Parent 1.16M USD -83.8%
Earnings Per Share, Basic 0.12 USD/shares -60%
Earnings Per Share, Diluted 0.12 USD/shares -60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.52K USD -97.7%
Assets, Current 1.58M USD +208%
Assets 10.9M USD -94.4%
Accrued Liabilities, Current 449K USD +0.14%
Liabilities, Current 4.92M USD +426%
Deferred Income Tax Liabilities, Net 13.7K USD -63%
Liabilities 5.09M USD +178%
Retained Earnings (Accumulated Deficit) -3.46M USD -458%
Stockholders' Equity Attributable to Parent -3.46M USD -458%
Liabilities and Equity 10.9M USD -94.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.06M USD -255%
Net Cash Provided by (Used in) Financing Activities -184M USD
Net Cash Provided by (Used in) Investing Activities 186M USD +554808%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 5.19M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.52K USD -97.7%
Deferred Tax Assets, Valuation Allowance 436K USD +87.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 423K USD +116%
Deferred Income Tax Expense (Benefit) -35.6K USD
Deferred Tax Assets, Operating Loss Carryforwards 436K USD +87.6%
Deferred Federal Income Tax Expense (Benefit) -227K USD -21.1%
Preferred Stock, Shares Authorized 1M shares 0%
Current Federal Tax Expense (Benefit) 480K USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 13.7K USD -63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%